Related Experiment Video
Updated: Mar 2, 2026

Clinical Assessment of Spatiotemporal Gait Parameters in Patients and Older Adults
Published on: November 7, 2014
Older patients have increased risk of poor outcomes after low-velocity pedestrian-motor vehicle collisions
Gerard A Baltazar1, Parker Bassett1, Amy J Pate2
1Division of Trauma, Department of Surgery, St. Barnabas Hospital Health System, Bronx, NY, USA.
Background:
Motor vehicle collisions (MVCs) are a leading cause of injury in the US. While the probability of collision with a pedestrian (PMVC) has declined in recent years, the probability of a pedestrian fatality has risen. Our objective was to determine whether older age impacts potential outcomes in patients involved in low-velocity PMVCs.
Materials And Methods:
We performed a retrospective-cohort study of adult patients aged >14 years involved in low-velocity pedestrian-MVCs (<15 miles per hour [24.14 km/h]), presenting to an urban level I trauma center from January to November 2013. Subjects were identified via trauma registry and stratified: ages 15-49 years and ≥50 years. Electronic medical records were reviewed for demographics, vital signs, and laboratory results on initial presentation, presence or absence of systemic inflammatory response syndrome (SIRS), shock index (SI), injury-severity score (ISS), length of stay (LOS), and survival to discharge. For statistical analysis, χ2 or Student's t-tests were utilized.
Results:
Our study included 145 patients (77 female) with a mean age of 41.9±3 years; 95 patients were aged 15-49 years (mean 31.9±2.2 years), and 50 patients were aged ≥50 years or older (mean 62.44±2.9 years). Mean ISS was 10.05±1.95, mean SI was 0.68±0.03, and mean LOS was 3.67±0.57 days. A total of 41 patients met SIRS criteria on arrival, and nine patients expired (6.2%). Mean ISS (15.64±4.42 vs 7.1±1.64, P<0.001) and mean SI (0.75±0.07 vs 0.65±0.03, P=0.002) were higher in patients aged ≥50 years. Mean LOS was longer in older patients (5.22±1.14 vs 2.85±0.58 days, P<0.001). Older age was associated with SIRS on arrival (P=0.023) and associated with mortality (P=0.004).
Conclusion:
Age ≥50 years is associated with greater severity of injury and poor outcomes for patients involved in low-velocity PMVCs. Increased clinical attention and resource allocation should be directed toward older patients after low-velocity PMVCs.
Insights
Older adults (≥50 years) involved in low-velocity pedestrian-motor vehicle collisions (PMVCs) face increased injury severity and poorer outcomes. This highlights the need for focused clinical attention and resources for this demographic following such incidents.
Area of Science:
- Trauma Surgery
- Geriatric Medicine
- Public Health
Background:
- Motor vehicle collisions (MVCs) are a significant cause of injury in the US.
- Pedestrian fatalities from MVCs are rising despite declining collision rates.
- Investigating the impact of age on outcomes in low-velocity pedestrian-MVCs is crucial.
Purpose of the Study:
- To determine if older age influences outcomes in patients involved in low-velocity pedestrian-MVCs.
- To compare injury severity and patient outcomes between younger and older adult groups.
- To identify specific risk factors associated with age in pedestrian-MVCs.
Main Methods:
- Retrospective cohort study of adult patients (>14 years) in low-velocity pedestrian-MVCs (<15 mph).
- Patients stratified into two groups: 15-49 years and ≥50 years.
- Analysis of demographics, vital signs, SIRS, SI, ISS, LOS, and survival to discharge.
Main Results:
- Patients aged ≥50 years had significantly higher Injury Severity Scores (ISS) and Shock Index (SI).
- Older patients experienced longer Lengths of Stay (LOS) and higher rates of Systemic Inflammatory Response Syndrome (SIRS) on arrival.
- Age ≥50 was significantly associated with increased mortality (P=0.004).
Conclusions:
- Older age (≥50 years) is a significant risk factor for greater injury severity and adverse outcomes in low-velocity pedestrian-MVCs.
- Clinical attention and resource allocation should be prioritized for older patients sustaining low-velocity pedestrian-MVCs.
- Further research into preventative strategies and tailored treatment protocols for older pedestrians is warranted.
More Related Videos
Related Concept Videos
Drug Dosing: Geriatric Patients
Pharmacodynamics in Geriatric Patients: Effects of Age
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peripheral Artery Disease V: Postoperative Nursing Management
Peripheral Artery Disease III: Interprofessional Care
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

